ReviewBritish journal of pharmacology2014

Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.

Rianne Nederlof et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.